Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Conditions: Osteoporosis; Osteoporosis, Postmenopausal; Osteopenia; Bone Loss Intervention: Drug: Zoledronic acid Sponsor: University of Calgary Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials